Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-25T17:12:03.025Z Has data issue: false hasContentIssue false

Case 3 - The depressed bipolar patient on multiple medications

Published online by Cambridge University Press:  19 October 2021

Takesha Cooper
Affiliation:
University of California, Riverside
Gerald Maguire
Affiliation:
University of California, Riverside
Stephen Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Pretest self-assessment question (answer at the end of the case)

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allison, DB, Mentore, JL, Heo, M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156:1686–96. https://doi.org/10.1176/ajp.156.11.1686CrossRefGoogle ScholarPubMed
Biton, V, Mirza, W, Montouris, G, et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001; 56:172–7. https://doi.org/10.1212/wnl.56.2.172CrossRefGoogle ScholarPubMed
Bowden, CL, Calabrese, JR, McElroy, SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57:481–9. https://doi.org/10.1001/archpsyc.57.5.481CrossRefGoogle ScholarPubMed
Bozzatello, P, Brignolo, E, de Grandi, E, Bellino, S. Supplementation with omega-3 fatty acids in psychiatric disorders: a review of literature data. J Clin Med 2016; 5:67. https://doi.org/10.3390/jcm5080067CrossRefGoogle ScholarPubMed
Calabrese, JR, Sullivan, JR, Bowden, CL, et al. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 2002; 63:1012–19. https://doi.org/10.4088/jcp.v63n1110CrossRefGoogle ScholarPubMed
Carvalho, AF, Firth, J, Vieta, E. Bipolar disorder. N Engl J Med 2020; 383:5866. https://doi.org/10.1056/NEJMra1906193CrossRefGoogle ScholarPubMed
Chengappa, KNR, Rathore, D, Levine, J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999; 1:4253. https://doi.org/10.1034/j.1399-5618.1999.10111.xCrossRefGoogle ScholarPubMed
Dunner, DL. Optimizing lithium treatment. J Clin Psychiatry 2000; 61 (Suppl. 9):7681.Google ScholarPubMed
Fountoulakis, KN, Grunze, H, Vieta, E, et al. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines. Int J Neuropsychopharmacol 2017; 20:18095. https://doi.org/10.1093/ijnp/pyw109Google ScholarPubMed
Frye, MA, Ketter, TA, Kimbrell, TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20:607–14. https://doi.org/10.1097/00004714-200012000-00004CrossRefGoogle ScholarPubMed
Gidal, BE, Maly, MM, Nemire, RE, Haley, K. Weight gain and gabapentin therapy. Ann Pharmacother 1995; 29:1048. https://doi.org/10.1177/106002809502901019CrossRefGoogle ScholarPubMed
Goodwin, GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346–88. https://doi.org/10.1177/0269881109102919CrossRefGoogle ScholarPubMed
Keck, PE Jr, McElroy, SL. Redefining mood stabilization J Affect Disord 2003; 73:163–9. https://doi.org/10.1016/s0165-0327(01)00355-xCrossRefGoogle ScholarPubMed
Knowles, SR, Shapiro, LE, Shear, NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999; 21:489501. https://doi.org/10.2165/00002018-199921060-00005CrossRefGoogle ScholarPubMed
Mallinger, AG, Thase, ME, Haskett, R, et al. Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. Bipolar Disord 2008; 10:856–66. https://doi.org/10.1111/j.1399-5618.2008.00636.xCrossRefGoogle Scholar
McElroy, S, Suppes, T, Keck, PE Jr, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000; 47:1025–33. https://doi.org/10.1016/s0006-3223(99)00316-9CrossRefGoogle ScholarPubMed
Melkersson, KI, Hulting, A-L, Brismar, KE. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000; 61:742–9. https://doi.org/10.4088/jcp.v61n1006CrossRefGoogle ScholarPubMed
Physicians’ Desk Reference, 56th edn. Montvale, NJ: Medical Economics Company, 2002.Google Scholar
Rosa, AR, Fountoulakis, K, Siamouli, M, et al. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. CNS Neurosci Ther 2011; 17: 167–77. https://doi.org/10.1111/j.1755-5949.2009.00089.xCrossRefGoogle Scholar
Sanger, TM, Grundy, SL, Gibson, PJ, et al. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry 2001; 62:273–81. https://doi.org/10.4088/jcp.v62n0410CrossRefGoogle ScholarPubMed
Schein, F, Manoli, P, Cathébras, P. Lithium-induced downbeat nystagmus. Am J Ophthalmol Case Rep 2017; 7:74–5. https://doi.org/10.1016/j.ajoc.2017.06.012Google ScholarPubMed
Schlienger, RG, Shear, NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39 (Suppl. 7):S37. https://doi.org/10.1111/j.1528-1157.1998.tb01678.xCrossRefGoogle ScholarPubMed
Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th edn. Cambridge, UK: Cambridge University Press, 2017.Google Scholar
Tohen, M, Sanger, TM, McElroy, SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156:702–9. https://doi.org/10.1176/ajp.156.5.702CrossRefGoogle ScholarPubMed
Tohen, M, Jacobs, TG, Grundy, SL, et al. for the Olanzapine HGGW Study Group. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000; 57:841–9. https://doi.org/10.1001/archpsyc.57.9.841CrossRefGoogle Scholar
Young, LT, Robb, JC, Patelis-Siotis, I, et al. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997; 42:851–3. https://doi.org/10.1016/s0006-3223(97)00305-3CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×